Physiologically based synthetic models of hepatic disposition

被引:42
|
作者
Hunt, C. Anthony
Ropella, Glen E. P.
Yan, Li
Hung, Daniel Y.
Roberts, Michael S.
机构
[1] Univ Calif San Francisco, Dept Biopharmaceut Sci, Biosyst Grp, San Francisco, CA 94143 USA
[2] Univ Queensland, Princess Alexandra Hosp, Sch Med, Brisbane, Qld 4102, Australia
基金
英国医学研究理事会;
关键词
physiologically based; liver; modeling (modelling); simulation; discrete event; agent-based;
D O I
10.1007/s10928-006-9031-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Current Physiologically based pharmacokinetic (PBPK) models are inductive. We present an additional, different approach that is based on the synthetic rather than the inductive approach to modeling and simulation. It relies on object-oriented programming A model of the referent system in its experimental context is synthesized by assembling objects that represent components such as molecules, cells, aspects of tissue architecture, catheters, etc. The single pass perfused rat liver has been well described in evaluating hepatic drug pharmacokinetics (PK) and is the system on which we focus. In silico experiments begin with administration of objects representing actual compounds. Data are collected in a manner analogous to that in the referent PK experiments. The synthetic modeling method allows for recognition and representation of discrete event and discrete time processes, as well as heterogeneity in organization, function, and spatial effects. An application is developed for sucrose and antipyrine, administered separately and together PBPK modeling has made extensive progress in characterizing abstracted PK properties but this has also been its limitation. Now, other important questions and possible extensions emerge. How are these PK properties and the observed behaviors generated? The inherent heuristic limitations of traditional models have hindered getting meaningful, detailed answers to such questions. Synthetic models of the type described here are specifically intended to help answer such questions. Analogous to wet-lab experimental models, they retain their applicability even when broken apart into sub-components. Having and applying this new class of models along with traditional PK modeling methods is expected to increase the productivity of pharmaceutical research at all levels that make use of modeling and simulation.
引用
收藏
页码:737 / 772
页数:36
相关论文
共 50 条
  • [31] Physiologically-based pharmacokinetic (PBPK) model to describe the disposition of pyronaridine
    Diep, John K.
    Lingerfelt, Mary A.
    Ekins, Sean
    Rao, Gauri G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S34 - S34
  • [32] Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy
    Alqahtani, Saeed
    Kaddoumi, Amal
    PLOS ONE, 2015, 10 (10):
  • [33] Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model
    Björkman, S
    Wada, DR
    Berling, BM
    Benoni, G
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (09) : 1226 - 1241
  • [34] A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL OF GEFITINIB DISPOSITION: FROM RAT TO MAN
    Deng, J.
    Lesko, L.
    An, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S52 - S52
  • [35] PREDICTION OF FTORAFUR DISPOSITION IN RATS AND MAN BY A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL
    SAKIYA, Y
    TSUEMURA, Y
    SAWADA, Y
    HANANO, M
    MARUNAKA, T
    UMENO, Y
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 25 (03) : 347 - 358
  • [36] Physiologically based pharmacokinetic modeling of chloroethane disposition in mice, rats, and women
    Gargas, Michael L.
    Sweeney, Lisa M.
    Himmelstein, Matthew W.
    Pottenger, Lynn H.
    Bus, James S.
    Holder, James W.
    TOXICOLOGICAL SCIENCES, 2008, 104 (01) : 54 - 66
  • [37] A physiologically based pharmacokinetic and pharmacodynamic model for disposition of FF-10832
    Matsumoto, Takeshi
    Masuo, Yusuke
    Tanaka, Anna
    Kimura, Toshifumi
    Ioroi, Tadaaki
    Yamakawa, Tatsuya
    Kitahara, Hiromu
    Kato, Yukio
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 627
  • [38] PREDICTION OF DIAZEPAM DISPOSITION IN THE RAT AND MAN BY A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL
    IGARI, Y
    SUGIYAMA, Y
    SAWADA, Y
    IGA, T
    HANANO, M
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1983, 11 (06): : 577 - 593
  • [39] A physiologically based pharmacokinetic model of docetaxel disposition: from mouse to man
    Bradshaw-Pierce, Erica L.
    Eckhardt, S. Gail
    Gustafson, Daniel L.
    CLINICAL CANCER RESEARCH, 2007, 13 (09) : 2768 - 2776
  • [40] Prediction of pharmacokinetics prior to in vivo studies.: II.: Generic physiologically based pharmacokinetic models of drug disposition
    Poulin, P
    Theil, FP
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (05) : 1358 - 1370